LDR | |
01218nam a22003378a 4500 |
001 |
|
004937153 |
003 |
|
MiAaHDL |
005 |
|
20241119000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
040701s2004 nju b 001 0 eng |
010 |
⊔ |
⊔ |
‡a2004048819
|
020 |
⊔ |
⊔ |
‡a0470869984
‡q(alk. paper)
|
035 |
⊔ |
⊔ |
‡a(MiU)990049371530106381
|
035 |
⊔ |
⊔ |
‡asdr-miu.990049371530106381
|
035 |
⊔ |
⊔ |
‡z(MiU)MIU01000000000000004937153-goog
|
035 |
⊔ |
⊔ |
‡a(OCoLC)55877555
|
035 |
⊔ |
⊔ |
‡z(MiU)Aleph004937153
|
040 |
⊔ |
⊔ |
‡aDLC
‡cDLC
‡dDLC
|
042 |
⊔ |
⊔ |
‡apcc
|
050 |
0 |
0 |
‡aQP552.S65
‡bB566 2004
|
082 |
0 |
0 |
‡a612/.015756
‡222
|
245 |
0 |
0 |
‡aBiology of IGF-1 :
‡bits interaction with insulin in health and malignant states /
‡c[edited by] Gregory Bock, Jamie Goode.
|
260 |
⊔ |
⊔ |
‡aHoboken, N.J. :
‡bJohn Wiley & Sons,
‡c2004.
|
300 |
⊔ |
⊔ |
‡a1 v. ;
‡c23 cm.
|
490 |
0 |
⊔ |
‡aNovartis Foundation symposium ;
‡v262
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographical references and index.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aCarcinogenesis
‡vCongresses.
|
650 |
⊔ |
0 |
‡aSomatomedin
‡xPathophysiology
‡vCongresses.
|
650 |
⊔ |
0 |
‡aSomatomedin
‡xPhysiological effect
‡vCongresses.
|
700 |
1 |
⊔ |
‡aGoode, Jamie.
|
700 |
1 |
⊔ |
‡aBock, Gregory.
|
899 |
⊔ |
⊔ |
‡a39015059173685
|
CID |
⊔ |
⊔ |
‡a004937153
|
DAT |
0 |
⊔ |
‡a20241118214845.0
‡b20241119000000.0
|
DAT |
1 |
⊔ |
‡a20241119060857.0
‡b2024-11-19T19:37:38Z
|
DAT |
2 |
⊔ |
‡a2024-02-28T18:30:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-MIU
‡cmiu
‡dALMA
‡lprepare.pl-004-008
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-miu.990049371530106381
‡aMiU
‡bSDR
‡cMIU
‡f004937153
‡pmdp.39015059173685
‡sMIU
‡1990049371530106381
|
974 |
⊔ |
⊔ |
‡bMIU
‡cMIU
‡d20241119
‡sgoogle
‡umdp.39015059173685
‡y2004
‡ric
‡qbib
‡tUS bib date1 >= 1929
|